Literature DB >> 33234721

The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization.

Shuiqing Wu1, Ran Xu1, Xuan Zhu1, Haiqing He1, Jinhua Zhang1, Qi Zeng1, Yinhuai Wang1, Xiaokun Zhao1.   

Abstract

MIBC (muscle invasive bladder cancer) only accounts for only a minority of bladder cancers, however, the disease-specific and overall survival rates of patients with MIBC are low. Macrophage M2 polarization has been reported to be associated with poorer prognosis in bladder cancer. Through cancer bioinformatics and experimental analyses, FGF9 was found to be upregulated in MIBC tissues. FGF9 knockdown in T24 cells strongly suppressed the viability, migratory capacity, and invasive capacity of cells; culture with medium from FGF9 knockdown T24 cells (si-FGF9-CM) significantly inhibited macrophage M2 polarization, while promoting M1 polarization. The long noncoding RNA (lncRNA) LINC01140 was positively correlated with FGF9 and was significantly upregulated in MIBC tissues. LINC01140 knockdown inhibited the viability, migratory capacity and invasive capacity of T24 cells; culture in si-LINC01140-CM also inhibited macrophage M2 polarization, while promoting M1 polarization. LINC01140 targeted miR-140-5p, while miR-140-5p targeted FGF9 to form a lncRNA-miRNA-mRNA axis. The effects of miR-140-5p inhibition on bladder cancer aggressiveness and macrophage M2 polarization were opposite to those of LINC01140 or FGF9 knockdown; additionally, miR-140-5p inhibition partially reversed the effects of LINC01140 knockdown on FGF9 protein levels, bladder cancer phenotype, and macrophage M2 polarization. In conclusion, LINC01140, miR-140-5p, and FGF9 form a lncRNA-miRNA-mRNA axis that modulates the bladder cancer phenotype, affects macrophage M2 polarization through the tumor microenvironment, and in turn affects bladder cancer cell aggressiveness.

Entities:  

Keywords:  FGF9; MIBC (muscle invasive bladder cancer); long non-coding RNA LINC01140; macrophage M2 polarization; miR-140-5p

Mesh:

Substances:

Year:  2020        PMID: 33234721      PMCID: PMC7803526          DOI: 10.18632/aging.202147

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  62 in total

Review 1.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  Purification of two forms of colony-stimulating factor from mouse L-cell-conditioned medium.

Authors:  A W Burgess; D Metcalf; I J Kozka; R J Simpson; G Vairo; J A Hamilton; E C Nice
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

3.  LncRNA KCNQ1OT1 ameliorates particle-induced osteolysis through inducing macrophage polarization by inhibiting miR-21a-5p.

Authors:  Xuren Gao; Jian Ge; Weiyi Li; Wangchen Zhou; Lei Xu
Journal:  Biol Chem       Date:  2018-03-28       Impact factor: 3.915

4.  A molecular taxonomy for urothelial carcinoma.

Authors:  Gottfrid Sjödahl; Martin Lauss; Kristina Lövgren; Gunilla Chebil; Sigurdur Gudjonsson; Srinivas Veerla; Oliver Patschan; Mattias Aine; Mårten Fernö; Markus Ringnér; Wiking Månsson; Fredrik Liedberg; David Lindgren; Mattias Höglund
Journal:  Clin Cancer Res       Date:  2012-05-02       Impact factor: 12.531

5.  Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a.

Authors:  Yun-Xiao Zhou; Wei Zhao; Li-Wei Mao; Yan-Li Wang; Li-Qun Xia; Min Cao; Jie Shen; Jun Chen
Journal:  Int J Biochem Cell Biol       Date:  2018-08-31       Impact factor: 5.085

6.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

7.  Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.

Authors:  Keiko Ohgino; Kenzo Soejima; Hiroyuki Yasuda; Yuichiro Hayashi; Junko Hamamoto; Katsuhiko Naoki; Daisuke Arai; Kota Ishioka; Takashi Sato; Hideki Terai; Shinnosuke Ikemura; Satoshi Yoda; Tetsuo Tani; Aoi Kuroda; Tomoko Betsuyaku
Journal:  Lung Cancer       Date:  2013-10-30       Impact factor: 5.705

8.  Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.

Authors:  Chengliu Jin; Fen Wang; Xiaochong Wu; Chundong Yu; Yongde Luo; Wallace L McKeehan
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.

Authors:  Yasin Şenbabaoğlu; Ron S Gejman; Andrew G Winer; Ming Liu; Eliezer M Van Allen; Guillermo de Velasco; Diana Miao; Irina Ostrovnaya; Esther Drill; Augustin Luna; Nils Weinhold; William Lee; Brandon J Manley; Danny N Khalil; Samuel D Kaffenberger; Yingbei Chen; Ludmila Danilova; Martin H Voss; Jonathan A Coleman; Paul Russo; Victor E Reuter; Timothy A Chan; Emily H Cheng; David A Scheinberg; Ming O Li; Toni K Choueiri; James J Hsieh; Chris Sander; A Ari Hakimi
Journal:  Genome Biol       Date:  2016-11-17       Impact factor: 13.583

10.  A three-lncRNA expression signature associated with the prognosis of gastric cancer patients.

Authors:  Peng Song; Bo Jiang; Zhijian Liu; Jie Ding; Song Liu; Wenxian Guan
Journal:  Cancer Med       Date:  2017-04-26       Impact factor: 4.452

View more
  6 in total

Review 1.  Emerging Roles of Long Noncoding RNAs in Immuno-Oncology.

Authors:  Xin Wang; Xu Wang; Midie Xu; Weiqi Sheng
Journal:  Front Cell Dev Biol       Date:  2021-11-25

Review 2.  Regulatory Mechanism of lncRNAs in M1/M2 Macrophages Polarization in the Diseases of Different Etiology.

Authors:  Ping Jiang; Xiaopeng Li
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

3.  Alpha-2 Heremans Schmid Glycoprotein (AHSG) promotes the proliferation of bladder cancer cells by regulating the TGF-β signalling pathway.

Authors:  Yufei Dong; Dapeng Ding; Juebin Gu; Mingying Chen; Shijun Li
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

4.  Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.

Authors:  Zi-Rong Jiang; Lin-Hui Yang; Liang-Zi Jin; Li-Mu Yi; Ping-Ping Bing; Jun Zhou; Jia-Sheng Yang
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

5.  miR-140-5p Aggravates Insulin Resistance via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells.

Authors:  Xuemei Li; Shujun Zhao; Yan Ye; Baoli Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-04       Impact factor: 3.168

6.  CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.

Authors:  Han Li; Fan Luo; Xingyu Jiang; Weijing Zhang; Tong Xiang; Qiuzhong Pan; Liming Cai; Jingjing Zhao; Desheng Weng; Yue Li; Yuhu Dai; Fengze Sun; Chaopin Yang; Yue Huang; Jieying Yang; Yan Tang; Yulong Han; Mian He; Yanna Zhang; Libing Song; Jian-Chuan Xia
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.